Ikena Oncology, Inc.

Contributing Author

Recent Articles by Ikena Oncology, Inc.

Jul-25	Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million GlobeNewswire
Jul-23	Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company GlobeNewswire
Jul-15	Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals GlobeNewswire
Jul-11	Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Merger with Inmagene Biopharmaceuticals GlobeNewswire